Will Triomics' oncology-specific AI platform be implemented in at least 5 major cancer centers in the United States by December 31, 2028?

The $22M funding aims to accelerate the adoption of their AI. Success in securing partnerships with multiple prominent cancer centers within a year would demonstrate significant market penetration and validation of their technology.

Implied probability (Yes)

45%

Closes

2030-08-25